Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 48 min ago
Peer-reviewedCC BY 4.0Journal of Clinical Medicine

Frontiers in the Risk Stratification and Prevention of Sudden Cardiac Arrest and Death in Athletes

  • Jacob Cushing1
  • Luke Hamar2
  • John Fritzlen1
  1. 1Department of Cardiovascular Medicine, The University of Kansas Medical Center, Kansas City, KS 66160, USA
  2. 2Department of Family Medicine, The University of Kansas Medical Center, Kansas City, KS 66160, USA
Read full textPDFDOICite

Abstract

Background: Sudden cardiac arrest (SCA) and sudden cardiac death (SCD) remain the leading causes of exercise-related mortality in athletes. Research in recent years has produced substantial advances in the understanding of athlete-specific risk, the etiologic spectrum of SCA/SCD, and the tools available for screening and risk stratification. Methods: We performed a narrative review of the literature identified through PubMed/MEDLINE searches of related terms, supplemented by targeted searches and reference checking. Summary of the Review: In this narrative review, we synthesize updated evidence on the epidemiology, etiologies, screening, and emerging technologies relevant to SCA/SCD in athletes. Conclusions: Contemporary evaluation of SCA/SCD risk in athletes relies on multimodal, individualized assessment with longitudinal surveillance and shared decision-making. Emerging computational tools may further refine risk prediction, but current evidence remains limited.

Related

  1. Cardiac screening in the young for the detection of cardiovascular disease and prevention of sudden cardiac death
    Daniel T Tardo, Sanjay Sharma
    PLOS MedicinePeer-reviewedCC BYFull textCardiovascular medicinePLOSEurope PMC
  2. Clinical Characteristics and Emergency Response to Sudden Cardiac Arrest/Death Secondary to Cardiomyopathies in Young Athletes
    Bradley J. Petek, Samantha L. Weller, Timothy W. Churchill +6
    JACC: AdvancesPeer-reviewedCC BY 4.0Full textCardiovascular medicinePMCDOAJ
  3. NKX2-5 mutation in a family with ventricular tachycardia and aborted sudden cardiac death.
    Abinash Pandey, Burt Bromberg, Dipika Menon
    HeartRhythm case reportsPeer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMC
  4. Research trends and hotspot analysis of sudden cardiac death in hypertrophic cardiomyopathy : A bibliometric analysis
    Zhen Chen, Fen Ai, Jinlei Li +1
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Genetic risk factors and causal associations with sudden cardiac arrest : A Mendelian randomization study
    Huaye Wu, Fengling Hu, Lin Liu +3
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{cushing2026frontiers,
  title = {{Frontiers in the Risk Stratification and Prevention of Sudden Cardiac Arrest and Death in Athletes}},
  author = {Jacob Cushing and Luke Hamar and John Fritzlen},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  month = oct,
  doi = {10.3390/jcm15207920},
  url = {https://www.mdpi.com/2077-0383/15/20/7920},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Frontiers in the Risk Stratification and Prevention of Sudden Cardiac Arrest and Death in Athletes
AU  - Jacob Cushing
AU  - Luke Hamar
AU  - John Fritzlen
PY  - 2026
DA  - 2026/10/01
JO  - Journal of Clinical Medicine
DO  - 10.3390/jcm15207920
UR  - https://www.mdpi.com/2077-0383/15/20/7920
AB  - Background: Sudden cardiac arrest (SCA) and sudden cardiac death (SCD) remain the leading causes of exercise-related mortality in athletes. Research in recent years has produced substantial advances in the understanding of athlete-specific risk, the etiologic spectrum of SCA/SCD, and the tools available for screening and risk stratification. Methods: We performed a narrative review of the literature identified through PubMed/MEDLINE searches of related terms, supplemented by targeted searches and reference checking. Summary of the Review: In this narrative review, we synthesize updated evidence on the epidemiology, etiologies, screening, and emerging technologies relevant to SCA/SCD in athletes. Conclusions: Contemporary evaluation of SCA/SCD risk in athletes relies on multimodal, individualized assessment with longitudinal surveillance and shared decision-making. Emerging computational tools may further refine risk prediction, but current evidence remains limited.
SN  - 2077-0383
ER  -